Following the presentation of the NEO-MINDSET study in the Late Breaking Clinical Trials sessions at the European Society of Cardiology Congress (ESC 2025), Dr. Pedro Lemos from São Paulo, Brazil, and principal investigator of the study spoke exclusively with SOLACI about the results, scope, and clinical implications of this research.
The virtual event also featured the participation of a panel from SOLACI including Dr. Ricardo Costa from Brazil (President of SOLACI), Dr. Alejandro Ricalde from Mexico (Secretary), and Dr. Gustavo Vignolo from Uruguay (Scientific Director), for an interactive discussion at the end. NEO-MINDSET is a Latin American study conducted in Brazil with the participation of more than 3,400 patients. Its findings represent one more milestone on this topic with significant impact in clinical practice. This event is part of SOLACI’s special scientific coverage of the main highlights from ESC 2025.
Subscribe to our weekly newsletter
Get the latest scientific articles on interventional cardiology
, el Dr. Pedro Lemos, de São Paulo, Brasil, e investigador principal del estudio, dialogó en exclusiva con SOLACI sobre los resultados, el alcance y las implicancias clínicas de esta investigación.){kind=link}